Back to search

Article

Global trends of antimicrobial susceptibility of ceftaroline and ceftazidime-avibactam: a surveillance study from the ATLAS program (2012-2016)

2020-10-01

Abstract excerpt

<h4>Background: </h4> This study reports the global trends of antimicrobial susceptibility toceftaroline and ceftazidime-avibactam using data from the Antimicrobial Testing Leadership And Surveillance (ATLAS)programbetween2012and2016. <h4>Methods: </h4>: For the 2012-2016 ATLAS program, 205 medical centers located in Africa-Middle East (n=12), Asia-Pacific (n=32), Europe (n=94), Latin America (n=26), North America...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16aca08b-247e-5409-b13d-93d4e8ee02e8
DOI
10.21203/rs.3.rs-31962/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Global trends of antimicrobial susceptibility of ceftaroline and ceftazidime-avibactam: a surveillance study from the ATLAS program (2012-2016)DOI 10.21203/rs.3.rs-31962/v3
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates from United States Medical Centers in 2016-2018.Semantic proximity
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020Semantic proximity
Susceptibility of Ceftazidime-avibactam in bloodstream infections caused by multidrug-resistant Enterobacterales and Pseudomonas aeruginosaSemantic proximity
In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016–2020Semantic proximity
Antimicrobial Susceptibility of Enterobacterales causing Bloodstream Infection in United States Medical Centres: Comparison of Aztreonam-Avibactam with Beta-Lactams Active against Carbapenem-Resistant EnterobacteralesSemantic proximity
Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative BacteriaSemantic proximity
Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infectionsSemantic proximity
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitorsSemantic proximity
Resistance to ceftazidime–avibactam and underlying mechanismsSemantic proximity
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019-2021): emergence of complex resistance phenotypes.Semantic proximity
Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Levofloxacin-Resistant Escherichia Coli Collected from Four Geographic Regions, 2012–2018Semantic proximity
Molecular characterization of clinically isolated Pseudomonas aeruginosa with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021Semantic proximity
Select a neighboring publication to make it the new centre.